Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akio Yamasaki

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Anticancer Research|September 6, 2017
Hedgehog Inhibition Upregulates TRK Expression to Antagonize Tumor Suppression in Small Cell Lung Cancer CellsHideya Onishi, Katsuya Nakamura, Shuntaro Nagai, et al.
European Journal of Immunology|November 11, 2009
VEGFR2 is selectively expressed by FOXP3high CD4+ TregHiroyuki Suzuki, Hideya Onishi, Junji Wada, et al.
Oncology Reports|March 22, 2022
Cancer therapy that targets the Hedgehog signaling pathway considering the cancer microenvironment (Review)Hideya Onishi, Katsuya Nakamura, Kosuke Yanai, et al.
Cellular Immunology|August 15, 2016
Hedgehog signaling regulates PDL-1 expression in cancer cells to induce anti-tumor activity by activated lymphocytesHideya Onishi, Akiko Fujimura, Yasuhiro Oyama, et al.
Anticancer Research|February 7, 2016
Sugar-carrying Polystyrenes Facilitate Harvesting of APCs from MLRs: Possible Application of Sugar-carrying Polystyrenes to ImmunotherapyAkira Imaizumi, Hideya Onishi, Akio Yamasaki, et al.
Anticancer Research|December 1, 2017
Liprin-α4 as a Possible New Therapeutic Target for Pancreatic CancerAkio Yamasaki, Kazunori Nakayama, Akira Imaizumi, et al.
Hepato-Gastroenterology|August 19, 2008
Multiseptate gallbladder: report of a caseAkio Yamasaki, Kazuo Chijiiwa, Sei-ichiro Jimi, et al.
Anticancer Research|May 6, 2009
The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancerChizu Kameda, Haruo Tanaka, Akio Yamasaki, et al.
Cancer Letters|March 25, 2011
Dual blockade of phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways overcomes paclitaxel-resistance in colorectal cancerRui Xu, Kenji Nakano, Hironori Iwasaki, et al.
Oncotarget|April 21, 2017
Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancerMakoto Kawamoto, Hideya Onishi, Keigo Ozono, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Anticancer Research|September 6, 2017
Hedgehog Inhibition Upregulates TRK Expression to Antagonize Tumor Suppression in Small Cell Lung Cancer CellsHideya Onishi, Katsuya Nakamura, Shuntaro Nagai, et al.
European Journal of Immunology|November 11, 2009
VEGFR2 is selectively expressed by FOXP3high CD4+ TregHiroyuki Suzuki, Hideya Onishi, Junji Wada, et al.
Oncology Reports|March 22, 2022
Cancer therapy that targets the Hedgehog signaling pathway considering the cancer microenvironment (Review)Hideya Onishi, Katsuya Nakamura, Kosuke Yanai, et al.
Cellular Immunology|August 15, 2016
Hedgehog signaling regulates PDL-1 expression in cancer cells to induce anti-tumor activity by activated lymphocytesHideya Onishi, Akiko Fujimura, Yasuhiro Oyama, et al.
Anticancer Research|February 7, 2016
Sugar-carrying Polystyrenes Facilitate Harvesting of APCs from MLRs: Possible Application of Sugar-carrying Polystyrenes to ImmunotherapyAkira Imaizumi, Hideya Onishi, Akio Yamasaki, et al.
Anticancer Research|December 1, 2017
Liprin-α4 as a Possible New Therapeutic Target for Pancreatic CancerAkio Yamasaki, Kazunori Nakayama, Akira Imaizumi, et al.
Hepato-Gastroenterology|August 19, 2008
Multiseptate gallbladder: report of a caseAkio Yamasaki, Kazuo Chijiiwa, Sei-ichiro Jimi, et al.
Anticancer Research|May 6, 2009
The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancerChizu Kameda, Haruo Tanaka, Akio Yamasaki, et al.
Cancer Letters|March 25, 2011
Dual blockade of phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways overcomes paclitaxel-resistance in colorectal cancerRui Xu, Kenji Nakano, Hironori Iwasaki, et al.
Oncotarget|April 21, 2017
Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancerMakoto Kawamoto, Hideya Onishi, Keigo Ozono, et al.
Pageof 3